• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma

CY Cheah, D Joske, G Cull, M Gilbertson, SS Opat, CS Tam, A Wirth, JF Seymour

British Journal of Haematology | WILEY | Published : 2017

DOI: 10.1111/bjh.14187

Download PDF

University of Melbourne Researchers

Constantine Tam's Profile Picture
Constantine Tam Author

Andrew Wirth's Profile Picture
Andrew Wirth Author

John Seymour's Profile Picture
John Seymour Author

Citation metrics

11Scopus
8Web of Science
10Dimensions

Keywords

Rare Diseases
Science & Technology
Life Sciences & Biomedicine
Involvement
Lymphoma
Central Nervous System
Cancer
6.2 Cellular and Gene Therapies
Stem Cell Research - Nonembryonic - Non-Human
3211 Oncology and Carcinogenesis
Trial
Diffuse Large B-Cell Lymphoma
Lymphatic Research
Non-Hodgkin-Lymphoma
Stem Cell Research
Rituximab
32 Biomedical and Clinical Sciences
Hematology
3201 Cardiovascular Medicine and Haematology
Autologous Stem Cell Transplant
Prophylaxis
Regenerative Medicine
Phase-Ii
Transplantation
5.2 Cellular and Gene Therapies
Orphan Drug
Stem Cell Research - Nonembryonic - Human
6.1 Pharmaceuticals

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224